Headline News about Allogene Therapeutics Inc
Allogene Therapeutics's Return On Capital Employed Insights
March 03, 2023
Via Benzinga
Via Benzinga
5 Analysts Have This to Say About Allogene Therapeutics
January 24, 2023
Via Benzinga
Expert Ratings for Allogene Therapeutics
January 06, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 24, 2023
January 24, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023
January 06, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
December 23, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
December 12, 2022
Via Benzinga
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.